Nature Reviews Cancer

Papers
(The H4-Index of Nature Reviews Cancer is 70. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Computing brain metastasis impact705
Digging for treasures in the tumour interactome679
Combining spatial transcriptomics and AI to enhance brain tumour diagnosis483
Combinatorial strategies to target RAS-driven cancers475
Claudin proteins as emerging therapeutic targets for solid tumours462
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment418
Emerging strategies to investigate the biology of early cancer375
Exploiting metabolic cell death for cancer therapy368
Oncofetal reprogramming in tumour development and progression302
INVADEseq to study the intratumoural microbiota at host single-cell resolution295
Fructose takes a detour to feed cancer292
Implementing practice-changing progress for managing cancer of unknown primary290
Mapping the prostate cell family tree276
Fighting cancer with fat271
Reply to ‘Heterogeneity of TP53 mutations necessitates differentiation with p53-rescue therapies’262
The evolution of cancer and ageing: a history of constraint260
Tertiary lymphoid structures as hubs of antitumour immunity255
3D chromatin architecture as a predictor of somatic mutations in cancer genomes252
Connie J. Eaves (1944–2024)250
The recruitment of metastasis-associated monocytes248
Author Correction: Fighting rare cancers: lessons from fibrolamellar hepatocellular carcinoma223
How medical anthropology can contribute to cancer research220
Translating premalignant biology to accelerate non-small-cell lung cancer interception214
Beyond genetics: driving cancer with the tumour microenvironment behind the wheel212
Avoiding cancer through collective behaviour209
The role of CRAF in cancer progression: from molecular mechanisms to precision therapies199
Epithelial and stromal co-evolution and complicity in pancreatic cancer194
Nanoreceptors take down mutant p53192
Impersonating neurons188
Tumour EVPs disrupt liver function187
AACR 2025185
Measuring HLA disruption using MHC Hammer183
Gut microbes produce novel genotoxic metabolites182
Persistence is key174
Thelpers? More like Ttroublemakers171
Defining a ‘cells to society’ research framework for appendiceal tumours166
No mutation, tumour initiation164
Moonlighting functions of glucose metabolic enzymes and metabolites in cancer164
3D bioprinted cancer models: from basic biology to drug development160
Rethinking ovarian cancer III: the past decade and future directions157
Dendritic cells rise and shine153
Removing barriers to address sex differences in anticancer drug toxicity151
Natural killer cells in antitumour adoptive cell immunotherapy148
How chemokines organize the tumour microenvironment148
Bone voyage: immune crosstalk sets sail139
B-ring sterols to the rescue139
Visualizing intratumoural heterogeneity with EpicMIBI128
Double trouble for the tumour glycocode127
Identifying spatial cellular structures with SPACE-GM126
In-depth organoid profiling of pancreatic cancer123
Environmental endocrine disruptors: rethinking the origins of early-onset ER+ breast cancer120
Enhancer and metabolic rewiring by KMT2C–COMPASS or KMT2D–COMPASS family loss in cancer creates druggable vulnerabilities118
Context-dependent synthetic lethality — an emerging precision therapeutic approach115
Opportunities and challenges of targeting cGAS–STING in cancer113
Linking cell mechanical memory and cancer metastasis109
The path to leptomeningeal metastasis108
The immune microenvironment of colorectal cancer104
Dynamics and specificities of T cells in cancer immunotherapy101
Metabolic interplays between the tumour and the host shape the tumour macroenvironment98
Regulatory T cells in the tumour microenvironment98
Leveraging the replication stress response to optimize cancer therapy95
Encoding spatial tumour dynamics with Starfysh94
Understanding and addressing race disparities in childhood cancer outcomes94
Race influences the tumour microbiome94
Cancer nanomedicine91
Deciphering the cancer genome and epigenome91
Advancing AI for multi-omics and clinical data integration in basic and translational cancer research83
The link between vitamin D and prostate cancer81
RNA splicing dysregulation and the hallmarks of cancer76
ER stress sparks nerve pain73
0.10810899734497